Page last updated: 2024-08-21

malondialdehyde and gw9662

malondialdehyde has been researched along with gw9662 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, D; Yao, SL; Zeng, BX; Zhang, SH1
Kobara, M; Nakata, T; Noda, K; Toba, H; Tojo, C; Wang, J1
Eslami, H; Rahati, M; Rahimi, H; Sharifi, AM1
Cui, Y; Deng, M; Qi, ZG; Shang, X; Wang, XL; Xie, ML; Xue, J; Zhang, Y; Zhao, X1
Askari, VR; Mousavi, SH; Rahimi, VB1
Askari, VR; Baradaran Rahimi, V; Mousavi, SH1

Other Studies

6 other study(ies) available for malondialdehyde and gw9662

ArticleYear
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2005, Volume: 54, Issue:11

    Topics: Anilides; Animals; Anti-Inflammatory Agents; Blotting, Western; Chemokine CXCL1; Chemokines, CXC; Endotoxemia; Immunohistochemistry; Intercellular Adhesion Molecule-1; Intercellular Signaling Peptides and Proteins; Lipid Peroxidation; Lung; Male; Malondialdehyde; Neutrophil Infiltration; NF-kappa B; Peroxidase; Pneumonia; PPAR gamma; Pulmonary Edema; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha

2005
Telmisartan inhibits vascular dysfunction and inflammation via activation of peroxisome proliferator-activated receptor-γ in subtotal nephrectomized rat.
    European journal of pharmacology, 2012, Jun-15, Volume: 685, Issue:1-3

    Topics: Acetylcholine; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Aorta; Benzimidazoles; Benzoates; Blood Urea Nitrogen; Disease Models, Animal; Inflammation; Kidney Failure, Chronic; Losartan; Male; Malondialdehyde; Nephrectomy; PPAR gamma; Rats; Rats, Wistar; Telmisartan; Vasodilation

2012
Protective effect of telmisartan against oxidative damage induced by high glucose in neuronal PC12 cell.
    Neuroscience letters, 2014, Jan-13, Volume: 558

    Topics: Angiotensin II Type 2 Receptor Blockers; Anilides; Animals; Antioxidants; Apoptosis; Benzimidazoles; Benzoates; Catalase; Cell Survival; Glucose; Glutathione; Malondialdehyde; NADP; Neuroprotective Agents; Oxidative Stress; PC12 Cells; PPAR gamma; Rats; Reactive Oxygen Species; Superoxide Dismutase; Telmisartan

2014
PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Cytokine, 2015, Volume: 75, Issue:1

    Topics: Anilides; Animals; Chemokine CCL2; Cytokines; Disease Models, Animal; Fatty Acids, Nonesterified; Fenofibrate; Gene Expression Regulation; Glutathione; Indoles; Inflammation; Interleukin-6; Interleukin-8; Lipid Metabolism; Liver; Male; Malondialdehyde; NF-kappa B; Non-alcoholic Fatty Liver Disease; Oxidative Stress; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones; Tumor Necrosis Factor-alpha

2015
Ellagic acid reveals promising anti-aging effects against d-galactose-induced aging on human neuroblastoma cell line, SH-SY5Y: A mechanistic study.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 108

    Topics: Aging; Anilides; beta-Galactosidase; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Ellagic Acid; Galactose; Glutathione; Glycation End Products, Advanced; Humans; Malondialdehyde; Mannitol; Metformin; Neuroblastoma; Protoporphyrins; Reactive Oxygen Species; Tumor Necrosis Factor-alpha

2018
Ellagic acid dose and time-dependently abrogates d-galactose-induced animal model of aging: Investigating the role of PPAR-γ.
    Life sciences, 2019, Sep-01, Volume: 232

    Topics: Aging; Anilides; Animals; Apoptosis; Brain; Ellagic Acid; Galactose; Glutathione Peroxidase; Liver; Male; Malondialdehyde; Metformin; Mice; Models, Animal; Oxidative Stress; PPAR gamma; Superoxide Dismutase; Tumor Necrosis Factor-alpha

2019